.Damien Hardwick Afl coach ex player backing along with other high profile athletes trial for cbd for cronic pain 7 news 1st December 2021
Zelira Therapeutics Ltd's (ASX:ZLD) (OTCMKTS:ZLDAF) Dr Oludare Odumosu and Levin Health Limited's Mark Brayshaw discuss plans for its upcoming chronic pain clinical trial. Levin will use Zelira's ZTL-106 formulation for testing on retired athletes in a chronic pain treatment study at La Trobe University in Melbourne. The trial will be sponsored by Levin, which will pay Zelira to design and manage the study, while both companies will share any commercialisation profits
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.520M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 34234 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 5666 | 1 |
View Market Depth
| Last trade - 16.21pm 16/09/2025 (20 minute delay) ? |
| ZLD (ASX) Chart |
Day chart unavailable